Introduction of Pharma

Online and Retail

Support with online users behaviour

Increase in ecommerce purchase

1) Retail Pharma
The retail pharma market in India is currently at a promising stage with its three broad
segments of generic drugs, OTC drugs, and patented products. Generic drugs form the
largest segment of the Indian pharmaceutical sector, with around 70% market share in
terms of revenue. OTC medicines and patented drugs constitute 21% and 9%,
respectively, of the total market revenues of around US $20 Billion.

The domestic pharma retail market, valued around INR 98,000 Crore (2015), is
primarily driven by the anti-infective market at 15.17%, cardiac drugs market at
12.47%, gastrointestinal drugs market at 11.75%, vitamins / minerals / nutrients
market at 8.78%, and anti-diabetic market at 8.13%
The Indian pharma industry, which is expected to grow over 15 per cent per annum
between 2015 and 2020, will outperform the global pharma industry, which is set to
grow at an annual rate of 5 per cent between the same period!. The market is expected
to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest
pharmaceutical market globally by absolute size, as stated by Mr Arun Singh, Indian
Ambassador to the US. Branded generics dominate the pharmaceuticals market,
constituting nearly 80 per cent of the market share (in terms of revenues).
India has also maintained its lead over China in pharmaceutical exports with a year-
on-year growth of 11.44 per cent to US$ 12.91 billion in FY 2015-16, according to
data from the Ministry of Commerce and Industry. In addition, Indian pharmaceutical
exports are poised to grow between 8-10 per cent in FY 2016-17. Imports of
pharmaceutical products rose marginally by 0.80 per cent year-on-year to US$
1,641.15 million.
Overall drug approvals given by the US Food and Drug Administration (USFDA) to
Indian companies have nearly doubled to 201 in FY 2015-16 from 109 in FY 2014-
15. The country accounts for around 30 per cent (by volume) and about 10 per cent
(value) in the US$ 70-80 billion US generics market.
 India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-
agriculture, bio-industry and bioinformatics is expected grow at an average growth
rate of around 30 per cent a year and reach US$ 100 billion by 2025. Biopharma,
comprising vaccines, therapeutics and diagnostics, is the largest sub-sector
contributing nearly 62 per cent of the total revenues at Rs 12,600 crore (US$ 1.89
billion).

Online Market
Online retailing is the big thing across sectors, including pharma. The $18-billion
market is set to grow to $55 billion by 2020 and is fast coming under the spotlight due
to its growth potential in the coming years. Online e-pharma startups in India have
already raised $92.6 million in funding so far.
Currently, India has about 45-50 e-pharma startups, major players being 1mg.com,
Bookmeds, mChemist, Medidart, Medlife, Medstar, Netmeds, Pharmeasy, Zigy.com
(PM Health & Life Care), SaveOnMedicals and Savemymeds.
Presently, online pharmacy is at its nascent stage in India, but like other categories, it
has the potential to be a very large industry segment. It is expected that the online
pharmacy model could account for 5-15% of the total pharma sales in India, largely
by enhancing adherence and access to the medicines for a lot of the under-served
population
The business is online pharmacies, and according to start-up data tracker Tracxn, so
far, the sector has attracted $92.6 million funding with over $70 million coming only
in 2015.
Almost 31 start-ups were launched last year, with the major chunk of investment
announced by Netmeds ($60 million), followed by 1MG ($6 million) and Zigy ($3.2
million).Investors include IT industry veteran Phaneesh Murthy (in Zigy) and global
healthcare fund Orbimed (in Netmeds).

Ecommerce User Base

India may have just 300-odd million Web clients, out of its aggregate populace of 1.3 billion.
In any case, this has not prevented online business from building up itself in the nation. For
some other industry, it requires many years of push to have organizations that are worth
billion dollars. In any case, in India, out of the nine startup unicorns, four are even online
commercial centers. Also, in spite of the current shutdowns and subsidizing crunch
influencing the startup biological system, computerized trade has set up itself. The most
recent review by the Web and Portable Relationship of India (IAMAI) has, indeed, found that
at a CAGR development rate of around 30 percent between December 2011 and December
2015, Indian advanced business remains at Rs 1,25,732 crore. The report gauges that it will
hit Rs 2,11,005 crore this year. Be that as it may, web based shopping comes simply
afteonline travel, which is esteemed near Rs 76,396 crore.